RSS   Newsletter   Contact   Advertise with us

Bardy Diagnostics appoints Alan J. Levy as director

Staff Writer | Seattle, Wa., USA | April 25, 2018
Bardy DiagnosticsBardy Diagnostics, a provider of ambulatory cardiac monitoring technologies and custom data solutions, announced the appointment of Alan J. Levy as an executive director.
Dr. Levy brings more than 40 years of senior operational leadership and entrepreneurial experience in the medical device industry.

Most recently, Dr. Levy served as the Chief Executive Officer and Chairman of the Board at Chrono Therapeutics.

In addition, he was a Senior Advisor and Venture Partner of Frazier Healthcare Partners focusing on the Life Science sector.

Dr. Levy's notable previous leadership experiences include serving as the founding Chief Executive Officer at Incline Therapeutics, Chief Executive Officer and President at Northstar Neuroscience, Chief Executive Officer and President at Heartstream, and President at Heart Technology that was acquired by Boston Scientific.

In addition, he held several leadership positions at Ethicon, a division of Johnson & Johnson, including serving as the Vice President of Research and New Business Development and Director.

Dr. Levy serves as a board member of several public and private companies including Intuitive Surgical, Proteus Digital Health and Seattle BioMed.

He received his PhD in Organic Chemistry from Purdue University, a BS in Chemistry from City University of New York, and holds an Honorary Doctor of Science from Purdue University.